These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28351905)
1. Comparison of Cisatracurium Versus Atracurium in Early ARDS. Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905 [TBL] [Abstract][Full Text] [Related]
2. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome. Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M; Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014 [TBL] [Abstract][Full Text] [Related]
3. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome. Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Fixed Dosing vs Train of Four Titration of Cisatracurium in COVID-19 ARDS Patients. Banerjee O; Elefritz JL; Doepker BA; Atyia SA; Brummel NE; Smith RM; Handley D; Cape KM J Pharm Pract; 2024 Oct; 37(5):1082-1090. PubMed ID: 38087423 [No Abstract] [Full Text] [Related]
6. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Needham CJ; Brindley PG Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702 [TBL] [Abstract][Full Text] [Related]
7. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome. Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813 [TBL] [Abstract][Full Text] [Related]
8. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation. Kressin C; Thompson Bastin M; Ather A; Gopinath A; Srour H; Schadler A; Pandya K J Clin Pharmacol; 2021 Nov; 61(11):1415-1420. PubMed ID: 34180067 [TBL] [Abstract][Full Text] [Related]
9. Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome. Riley K; Yampolsky N; Hakma Z; Moussouttas M Am J Health Syst Pharm; 2015 Apr; 72(8):632-5. PubMed ID: 25825186 [TBL] [Abstract][Full Text] [Related]
10. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study. Fraj N; Meddeb K; Azouzi A; Romdhani S; Saad HB; Boussarsar M Pan Afr Med J; 2020; 37():346. PubMed ID: 33738034 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome]. Lyu G; Wang X; Jiang W; Cai T; Zhang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261 [TBL] [Abstract][Full Text] [Related]
12. Comparison of fixed dose versus train-of-four titration of cisatracurium in acute respiratory distress syndrome. Thompson Bastin ML; Smith RR; Bissell BD; Wolf HN; Wiegand AM; Cavagnini ME; Ahmad Y; Flannery AH J Crit Care; 2021 Oct; 65():86-90. PubMed ID: 34118504 [TBL] [Abstract][Full Text] [Related]
13. Cisatracurium dosing in a patient with hyperthermia. Lim J; Cox J; Nguyen T; Arya R Am J Health Syst Pharm; 2019 Jul; 76(14):1029-1032. PubMed ID: 31361873 [TBL] [Abstract][Full Text] [Related]
14. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients. Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738 [TBL] [Abstract][Full Text] [Related]
15. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients. Pearson AJ; Harper NJ; Pollard BJ Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237 [TBL] [Abstract][Full Text] [Related]
16. Atracurium Versus Cisatracurium in the Treatment of Acute Respiratory Distress Syndrome. Carabetta SM; Allen B; Cannon C; Hailu K; Johnson T J Pharm Technol; 2023 Oct; 39(5):212-217. PubMed ID: 37745727 [No Abstract] [Full Text] [Related]
17. Neuromuscular blockers and ARDS. Gusmão D N Engl J Med; 2010 Dec; 363(26):2562-3; author reply 2563-4. PubMed ID: 21175321 [No Abstract] [Full Text] [Related]
18. Prolonged weakness after cisatracurium infusion: a case report. Davis NA; Rodgers JE; Gonzalez ER; Fowler AA Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384 [TBL] [Abstract][Full Text] [Related]
19. Neuromuscular Blockade Monitoring in Acute Respiratory Distress Syndrome: Randomized Controlled Trial of Clinical Assessment Alone or With Peripheral Nerve Stimulation. Rezaiguia-Delclaux S; Laverdure F; Genty T; Imbert A; Pilorge C; Amaru P; Sarfati C; Stéphan F Anesth Analg; 2021 Apr; 132(4):1051-1059. PubMed ID: 33002927 [TBL] [Abstract][Full Text] [Related]
20. PaO Roncon-Albuquerque R; Ferreira-Coimbra J; Vilares-Morgado R; Figueiredo P; Paiva JA Ann Thorac Surg; 2016 Dec; 102(6):1878-1885. PubMed ID: 27592605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]